Dexco S.A. (BVMF:DXCO3)

Brazil flag Brazil · Delayed Price · Currency is BRL
5.25
+0.02 (0.38%)
Apr 28, 2026, 5:07 PM GMT-3
7.49%
Market Cap 4.77B
Revenue (ttm) 8.25B
Net Income (ttm) 1.18M
Shares Out 907.65M
EPS (ttm) 0.00
PE Ratio 4,031.46
Forward PE 11.43
Dividend n/a
Ex-Dividend Date n/a
Volume 1,245,700
Average Volume 2,763,385
Open 5.21
Previous Close 5.23
Day's Range 5.13 - 5.25
52-Week Range 4.43 - 6.22
Beta 0.48
RSI 49.22
Earnings Date May 6, 2026

About Dexco

Dexco S.A., together with its subsidiaries, produces and sells wooden panels in Brazil and internationally. It operates through Wood Panels; Metals and Sanitary Ware; Coatings; and Soluble Pulp segments. The company offers medium density particulate panels, and medium and high-density fiberboard panels under the Duratex brand; and laminated floors and semifinished components for furniture under the Durafloor brand name. It also provides ceramic and cement flooring, as well as coatings under the Ceusa, Portinari, and Castelatto brands. The compa... [Read more]

Sector Materials
Founded 1951
Employees 14,228
Stock Exchange Brazil Stock Exchange
Ticker Symbol DXCO3
Full Company Profile

Financial Performance

In 2025, Dexco's revenue was 8.25 billion, an increase of 0.17% compared to the previous year's 8.23 billion. Earnings were 1.18 million, a decrease of -99.31%.

Financial Statements

News

Dexco Earnings Call Transcript: Q4 2025

Net revenue reached BRL 8.249 million in 2025, with strong wood and LD Celulose performance offsetting weakness in ceramic tiles and metals. Focus remains on deleveraging, cash generation, and portfolio optimization, with expectations for margin recovery in 2026.

7 weeks ago - Transcripts

Dexco Earnings Call Transcript: Q3 2025

Urgent deleveraging and cost control are driving operational focus, with positive cash flow and healthy wood division margins. Portfolio simplification, efficiency gains, and a transformation plan aim to improve ROIC and reduce leverage, while asset sales and outsourcing remain under review.

6 months ago - Transcripts

Dexco Earnings Call Transcript: Q2 2025

Q2 saw robust EBITDA growth, led by the wood division and LD Celulose, with improved margins and operational efficiency. De-leveraging initiatives, disciplined CapEx, and a positive outlook for wood and tiles support long-term resilience.

9 months ago - Transcripts

Dexco Earnings Call Transcript: Q1 2025

Q1 2025 saw resilient EBITDA and profitability in wood and LD Celulose, offset by challenges in tiles and finishing divisions. Leverage rose to 3.45x net debt/EBITDA, with capex and operational efficiency prioritized as the investment cycle winds down.

1 year ago - Transcripts

Dexco Earnings Call Transcript: Q4 2024

Wood and LD Celulose divisions drove strong 2024 results, with record EBITDA and revenue, while metals and sanitary ware recovered. Focus for 2025 is on deleveraging, cash generation, and ramping up new tile operations amid a challenging macroeconomic environment.

1 year ago - Transcripts

Dexco Earnings Call Transcript: Q3 2024

Strong wood division performance and record LD Celulose results drove a 60% year-over-year EBITDA increase, while metals and sanitary ware stabilized and tiles remained pressured. The company is nearing the end of a major investment cycle, focusing on deleveraging and operational optimization.

1 year ago - Transcripts

Dexco Earnings Call Transcript: Q2 2024

Quarterly adjusted EBITDA grew 8% year-over-year, led by strong wood and metals segments, while tiles faced ongoing challenges. CapEx for 2024 is guided at BRL 1.1–1.2 billion, with leverage rising due to investment cycle. Sustainability and ESG initiatives advanced.

1 year ago - Transcripts

Dexco Earnings Call Transcript: Q1 2024

2 years ago - Transcripts

Dexco Earnings Call Transcript: Q4 2023

2 years ago - Transcripts

Dexco Transcript: Q3 & Dexco Day 2023

2 years ago - Transcripts

Dexco Earnings Call Transcript: Q2 2023

2 years ago - Transcripts

Dexco Earnings Call Transcript: Q1 2023

3 years ago - Transcripts

Dexco Earnings Call Transcript: Q4 2022

3 years ago - Transcripts

Dexco Transcript: Q3 & Dexco Day 2022

3 years ago - Transcripts

Dexco Earnings Call Transcript: Q2 2022

4 years ago - Transcripts

Dexco Earnings Call Transcript: Q1 2022

4 years ago - Transcripts

Dexco Earnings Call Transcript: Q4 2021

4 years ago - Transcripts

Dexco Earnings Call Transcript: Q3 2021

4 years ago - Transcripts

Dexco Earnings Call Transcript: Q2 2021

5 years ago - Transcripts

Dexco Transcript: Duratex Day 2021

5 years ago - Transcripts

Dexco Earnings Call Transcript: Q1 2021

5 years ago - Transcripts